Hanbo High-tech (301321.SZ): Waiving the right of first refusal for the transfer of equity in the associated company Xin Dongjin

NightAirdropper · 2026-03-10T13:00:08+00:00

Hanbo High-tech and Beijing Xinjin and Chuxin Ruibo Fund established a joint venture company, Xin Dongjin, with a total investment of 44 million yuan. Hanbo High-tech holds a 45.4545% equity stake. Beijing Xinjin will transfer a 10% equity stake to Hanbo Holdings free of charge, and Hanbo High-tech has decided not to exercise its preemptive right.

NightAirdropper

2026-03-10 13:00:08

Abstract generation in progress

Gelonghui, March 9 — Hanbo High-tech (301321.SZ) announced that on December 1, 2025, the company’s 22nd meeting of the fourth board of directors approved the proposal for joint investment with professional investment institutions to establish a joint venture. The company, Beijing Xinjin Technology Co., Ltd. (referred to as “Beijing Xinjin”), Qingdao Chuxin Ruibo Venture Capital Partnership (Limited Partnership) (referred to as “Chuxin Ruibo Fund”), jointly invested to establish Hefei Xindongjin New Material Technology Co., Ltd. (referred to as “Xindongjin”). Xindongjin’s total registered capital is 440 million RMB, with Hanbo High-tech holding 45.4545%, Beijing Xinjin holding 45.4545%, and Chuxin Ruibo Fund holding 9.0910%.

Beijing Xinjin plans to transfer its 10% equity stake in Xindongjin (corresponding to a registered capital of 44 million RMB, unpaid) to Hanbo Holding Group Co., Ltd. (referred to as “Hanbo Holding”) at a price of 0 RMB. After the transfer, Xindongjin will still be an equity affiliate of the company. According to the “Company Law” and other relevant regulations, the company has the right of first refusal for this equity transfer. After careful consideration, the company has decided to waive this right.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.